| ¿µ¹® | risk factor | ÇÑ±Û | À§ÇèÀÎÀÚ |
|---|---|---|---|
| ¼³¸í | ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)°¡ 1977³â ±Ç°í¿¡¼ ¹æ»ç¼±¹æÈ£ÀÇ ¸ñÀûÀ¸·Î äÅÃÇÑ Áö¼ö·Î, ´ÜÀ§¼±·®(1 Sv)´ç È®·üÀû ¿µÇâÀÇ ¹ß»ýÈ®·üÀ» ÃßÁ¤ÇÏ¿© ³ªÅ¸³½ °ÍÀÌ´Ù. »ý½Ä¼± ¼±·®¿¡ ´ëÇÑ À¯ÀüÀû¿µÇâÀÇ ¹ß»ý·ü(4¡¿10£3/Sv)À̳ª Àû»ö°ñ¼ö¼±·®¿¡ ´ëÇÑ ¹éÇ÷º´ ¹ß»ý·ü(2¡¿10£3/Sv)µî ¿Ü¿¡ »À, ÇãÆÄ, °©»ó»ù, Á¥»ù, ±âŸ Á¶Á÷ÀÇ À§ÇèÁö¼ö¸¦ ÃøÁ¤ÇÏ¿©, È®·üÀû ¿µÇâÀÇ Àü½Å¿¡ ÀÖ¾î¼ Ä¡»çÀ§ÇèÁö¼öÀÇ Çհ踦 16.5¡¿10£3/Sv·Î ÇÏ¿´´Ù. ±×ÈÄ ICRP´Â 1990³â ±Ç°í¿¡¼ ´ë»óÀÌ µÇ´Â Á¶Á÷°ú Àå±â¸¦ Ãß°¡Çϰí, ¼öÄ¡ °³Á¤À» ÇÏ¸é¼ ¸íεµ °¢¸ñÀûÈ®·üÁö¼ö¶ó°íÇÏ¿´´Ù. ÀÌ ±Ç°í¿¡ ÀÇÇϸé, Ä¡»çÀû È®·üÀû ¿µÇâÀÇ È®·üÁö¼öÀÇ ÇÕ°è´Â, ÀϹÝÀο¡ ÀÖ¾î 60.0¡¿10£3/SvÀÌ´Ù. |
||
| ¿µ¹® | suicide | ÇÑ±Û | ÀÚ»ì |
|---|---|---|---|
| ¼³¸í | ½º½º·Î ÀÚ½ÅÀÇ ¸ñ¼ûÀ» ²÷À½. Áï, ÇàÀ§ÀÚ°¡ ÀÚ½ÅÀÇ Á×À½À» ÃÊ·¡ÇÒ Àǵµ¸¦ °¡Áö°í ÀÚ½ÅÀÇ »ý¸íÀ» ²÷´Â ÇàÀ§. ÀÚ»ìÀÇ ¿µ¾î´ëÀÀ¾îÀÎ suicideÀÇ ¾î¿øÀº ¶óƾ¾îÀÇ sui(ÀÚ±â ÀÚ½ÅÀ»)¿Í caedo(Á×ÀÌ´Ù)ÀÇ µÎ ³¹¸»ÀÇ ÇÕ¼º¾îÀÌ´Ù. ¿©±â¼ ¾Ë ¼ö ÀÖµíÀÌ, ÀÚ»ìÀ̶õ ±× ¿øÀÎÀÌ °³ÀÎÀûÀÌµç »çȸÀûÀ̵ç, ´ç»çÀÚ°¡ ÀÚÀ¯Àǻ翡 ÀÇÇÏ¿© ÀÚ½ÅÀÇ ¸ñ¼ûÀ» ²÷´Â ÇàÀ§¸¦ ¸»ÇÑ´Ù. ÀÌ Á¤ÀÇ´Â À졧 ¸í¹éÇϱâ´Â Çϳª ½ÇÁ¦·Î´Â ¿©·¯ ¹®Á¦°¡ ÀÖ´Ù. ÀÚ»ìÀÇ ¿øÀÎÀº º¹ÀâÇÏ°í ÆÄ¾ÇÇϱ⠾î·Á¿îµ¥, Åë°è¿¡ ÀÇÇÏ¸é ½Å°æ¼è¾à-½Ç¿¬-º´°í-»ýȰ°í-°¡Á¤ºÒÈ-Àå·¡¿¡ ´ëÇÑ °í¹Î-»ç¾÷½ÇÆÐ-¿°¼¼ µî ¿©·¯ °¡Áö°¡ ÀÖÀ¸¸ç, ±× Áß¿¡¼µµ ¿°¼¼-º´°í-½Å°æ¼è¾à-½Ç¿¬-°¡Á¤ºÒȰ¡ µÎµå·¯Áö°Ô ¸¹´Ù. À̰ÍÀ» ³²³àº°·Î º¸¸é ³²ÀÚ¿¡°Ô´Â ½Å°æ¼è¾à°ú º´°í°¡ ¸¹°í, ¿©ÀÚ¿¡°Ô´Â °¡Á¤ºÒÈ¿Í ½Ç¿¬ÀÌ ¸¹´Ù. ±×¸®°í ¿¬·Éº°·Î´Â û¼Ò³â¿¡¼´Â ½Ç¿¬°ú ¿°¼¼°¡ ¸¹°í, ³ëÀο¡¼´Â º´°í°¡ Ư¡ÀûÀ¸·Î ¸¹´Ù. °¡Á¤ºÒÈ´Â 20~30´ë¿¡ ¸¹´Ù. |
||
| AR | absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista... |
|---|---|
| CRI | Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins... |
| HRP | high-risk patient; high-risk pregnancy; histidine-rich protein; horseradish peroxidase |
| RR | radiation reaction; radiation response; rate ratio; rational recovery [group]; recovery room; relati... |
| MSDI | Martin Suicide Depression Inventory |
| PAS | Physician assisted suicide |
|---|---|
| ARR | Absolute risk reduction |
| aRR | Adjusted relative risk |
| AAR | Area at risk |
| AR | At-Risk |
| lesbian | Female homosexual. The name lesbian comes from the greek island of lesbos in the aegian sea where in antiquity the women were said to be homosexual. The poet sappho who lived on lesbos (circa 600 bc) was a lesbian in both geographic location and sexual orientation. (12 Dec 1998) |
|---|---|
| suicide | The act of killing oneself. (12 Dec 1998) |
| suicide, assisted | Deliberate acceleration of death of a competent patient with an incurable disease or in the extremes of suffering. The patient seeking assistance in taking his own life may ask the help of a physician or other health professional, a family member, or a friend. The milieu may be a hospital, nursing home, or private residence. Assistance to the person in dire physical or psychological distress may take the form of lethal doses of medications or chemicals to be taken orally or by injection through human intervention or with a so-called suicide machine. (12 Dec 1998) |
| suicide, attempted | The unsuccessful attempt to kill oneself. (12 Dec 1998) |
| suicide substrate | A competitive inhibitor that is converted to an irreversible inhibitor at the active site of the enzyme. Synonym: mechanism-based inhibitor. (05 Mar 2000) |
| absolute risk | <statistics> The excess risk due to exposure to a specific hazard (disease, injury, etc.) (15 Jan 1998) |
| acceptable risk | <statistics> This relates to the potential for suffering disease or injury that will be tolerated by an individual, group, or society in exchange for the benefits of using a substance or process that will cause such disease or injury. Acceptability of risk depends on scientific data, social, economic, and political factors, and on the perceived benefits arising from a chemical or process that creates the risk in question. (15 Jan 1998) |
| attributable risk | The rate of a disease or other outcome in exposed individuals that can be attributed to the exposure. (05 Mar 2000) |
| cardiac risk | A term to describe overall risk of developing heart disease (blockage of the coronary arteries). Typical risk factors include: diabetes, high blood pressure, prior heart attack, high cholesterol, obesity, smoking and a family history for heart attacks in parents or siblings. (27 Sep 1997) |
| recurrence risk | In medical genetics, the recurrence risk is the chance that a genetic (inherited) disease present in the family will recur in that family and affect another person (or persons). It is the chance of lightning striking twice (or thrice, etc.). (12 Dec 1998) |
| glaucoma, risk factors | If you belong to a high-risk group for glaucoma, have your eyes examined through dilated pupils every 2 years by an eye care professional. High-risk groups include everyone with a family history of glaucoma, everyone over the age of 60 and any Black over the age of 40. (Among Blacks, studies show that glaucoma is: 5 times more likely to occur in Blacks than in Whites and about 4 times more likely to cause blindness in Blacks than in Whites). (12 Dec 1998) |
| relative risk | <epidemiology> The proportion of diseased people amongst those exposed to the relevant risk factor divided by the proportion of diseased people amongst those not exposed to the risk factor. This should be used in those cohort studies where those with and without disease are followed to observe which individuals become diseased. (05 Dec 1998) |
| risk | The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. (12 Dec 1998) |
| risk assessment | The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (12 Dec 1998) |
| risk benefit | An analysis of risk versus benefit is a complex assessment that must be made by a physician prior to the administration of a particular form of drug therapy. Since many medications may have side effects that can be harmful (during the course of treatment), the overall risk of a particular form of drug therapy must be weighed against the overall threat of the untreated disease process (or treatment with an altenative drug). (27 Sep 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|